ATE176927T1 - Kontakt-vermitteltes hämolysin regulator - Google Patents
Kontakt-vermitteltes hämolysin regulatorInfo
- Publication number
- ATE176927T1 ATE176927T1 AT94919235T AT94919235T ATE176927T1 AT E176927 T1 ATE176927 T1 AT E176927T1 AT 94919235 T AT94919235 T AT 94919235T AT 94919235 T AT94919235 T AT 94919235T AT E176927 T1 ATE176927 T1 AT E176927T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- nucleic acid
- hemolysin
- regulator
- mediated
- Prior art date
Links
- 108010006464 Hemolysin Proteins Proteins 0.000 title abstract 2
- 239000003228 hemolysin Substances 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 2
- 206010018910 Haemolysis Diseases 0.000 abstract 1
- 241001467552 Mycobacterium bovis BCG Species 0.000 abstract 1
- 230000008588 hemolysis Effects 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6683093A | 1993-05-24 | 1993-05-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE176927T1 true ATE176927T1 (de) | 1999-03-15 |
Family
ID=22071994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94919235T ATE176927T1 (de) | 1993-05-24 | 1994-05-24 | Kontakt-vermitteltes hämolysin regulator |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5731151A (de) |
| EP (1) | EP0700440B1 (de) |
| JP (1) | JPH09501308A (de) |
| AT (1) | ATE176927T1 (de) |
| AU (1) | AU684798B2 (de) |
| CA (1) | CA2163438A1 (de) |
| DE (1) | DE69416673T2 (de) |
| WO (1) | WO1994028137A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3593200A (en) * | 1999-02-09 | 2000-08-29 | Powderject Vaccines, Inc. | (mycobacterium tuberculosis), immunization |
| JP3976685B2 (ja) * | 2000-11-22 | 2007-09-19 | ユニバーシティ オブ メリーランド， ボルチモア | タンパク質分泌のためのＣｌｙＡ溶血素の使用 |
| US6645505B2 (en) * | 2001-03-27 | 2003-11-11 | Council Of Scientific And Industrial Research | Reporter gene based method for the screening of anti-tuberculosis drugs by using essential and regulatory genes of mycobacteria as drug target |
| US20100047286A1 (en) * | 2004-12-01 | 2010-02-25 | Aeras Global Tb Vaccine Foundation | Recombinant BCG strains with enhanced ability to escape the endosome |
| US8398991B2 (en) * | 2005-06-22 | 2013-03-19 | Institut Pasteur | Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCG |
| US20060293261A1 (en) * | 2005-06-24 | 2006-12-28 | Taisho Pharmaceutical Co., Ltd. | Clarithromycin or a salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli |
| EP2294090B1 (de) * | 2008-06-03 | 2014-05-14 | University of Maryland, Baltimore | NICHT HÄMOLYTISCHES ClyA FÜR PROTEINAUSSCHEIDUNG |
-
1994
- 1994-05-24 US US08/557,115 patent/US5731151A/en not_active Expired - Fee Related
- 1994-05-24 JP JP7500923A patent/JPH09501308A/ja active Pending
- 1994-05-24 CA CA002163438A patent/CA2163438A1/en not_active Abandoned
- 1994-05-24 DE DE69416673T patent/DE69416673T2/de not_active Expired - Fee Related
- 1994-05-24 WO PCT/US1994/005869 patent/WO1994028137A1/en not_active Ceased
- 1994-05-24 AT AT94919235T patent/ATE176927T1/de not_active IP Right Cessation
- 1994-05-24 EP EP94919235A patent/EP0700440B1/de not_active Expired - Lifetime
- 1994-05-24 AU AU70452/94A patent/AU684798B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US5731151A (en) | 1998-03-24 |
| CA2163438A1 (en) | 1994-12-08 |
| JPH09501308A (ja) | 1997-02-10 |
| DE69416673T2 (de) | 1999-09-16 |
| DE69416673D1 (de) | 1999-04-01 |
| AU684798B2 (en) | 1998-01-08 |
| WO1994028137A1 (en) | 1994-12-08 |
| EP0700440B1 (de) | 1999-02-24 |
| EP0700440A1 (de) | 1996-03-13 |
| AU7045294A (en) | 1994-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL102712A0 (en) | Variety of bacillus thuringiensis,insecticide derived therefrom and dna encoding the insecticide | |
| YU48397B (sh) | Izolat trichoderma harzianum t-39 fungicidalna jedinjenja koja sadrže pomenuti izolat i upotreba protiv b. cinerea i s. sclerotiorum. | |
| DK1152012T3 (da) | Tuberkulosevacciner | |
| FR2771918B1 (fr) | Connecteur pour dispositif d'osteosynthese rachidienne | |
| GB0023203D0 (en) | Vaccination method | |
| DE69827779D1 (de) | Detoxifizierte mutanten bakterieller adp-ribosylierender toxine als parenterale adjuvantien | |
| NO20024246D0 (no) | Endret stamme av det modifiserte vacciniaviruset (Ankara MVA) | |
| FI954990A0 (fi) | Aktiiviainetta sisältävä transdermaalinen valmiste | |
| NZ312327A (en) | Controlling hemipteran insect pests with bacillus thuringiensis | |
| AU6974294A (en) | Release and mobilisation of haematopoietic cells | |
| ATE176927T1 (de) | Kontakt-vermitteltes hämolysin regulator | |
| ES8607020A1 (es) | Acidos 1-ciclopropilquinolon-3-carboxilicos | |
| HUP0105430A2 (hu) | Attenuált baktériumok, alkalmazásuk, továbbá a baktériumokat tartalmazó vakcinák | |
| GB9409985D0 (en) | Vaccine against mycobacterial infections | |
| DK0589943T3 (da) | Mycobacterium-proteiner og anvendelse heraf | |
| FI960269A0 (fi) | Erittän väkeviä kiinteitä mepikvaattikloridi- ja kloorimekvaattikloridituotteita | |
| PT914437E (pt) | Identificacao e clonagem de um antigenio micobacteriano correspondente a uma hemaglutinina de ligacao a heparina | |
| DK0946730T3 (da) | Mutanter af streptokok-toksin C og fremgangsmåder til anvendelse | |
| DK0821588T3 (da) | Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder | |
| HU9401333D0 (en) | 1,3,5-triazine-2,4,6-tris-alkylaminocarboxylic acid aminoesters, biocidal agents containing such esters, and methods of preparing them | |
| BR0009077A (pt) | Antìgenos de tuberculose e métodos de uso dos mesmos | |
| AU8090591A (en) | Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae | |
| NO982523D0 (no) | Holder for juletre eller lignende | |
| ATE183100T1 (de) | Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel | |
| BR0013574A (pt) | Antìgeno vacina de moraxella |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |